Which super funds hold PHARMARESEARCH CO. LTD.?

As at 31 December 2025, 12 Australian super investment options in our dataset held PHARMARESEARCH CO. LTD., the largest weighting being 0.00% in Lifecycle High Growth Pool (Accumulation) (Australian Retirement Trust).

Options holding it

12

Largest weighting

0.00%

Lifecycle High Growth Pool (Accumulation) · Australian Retirement Trust

Funds & options holding PHARMARESEARCH CO. LTD.

Australian super investment options disclosing a holding in PHARMARESEARCH CO. LTD.. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.

FundPhaseOptionWeightingValue (AUD)As at
Australian Retirement TrustAccumulationLifecycle High Growth Pool (Accumulation)
0.00%
$46,90731 December 2025
Australian Retirement TrustAccumulationDiversified High Growth (Accumulation)
0.00%
$17,99231 December 2025
Australian Retirement TrustAccumulationLifecycle Balanced Pool (Accumulation)
0.00%
$15,31831 December 2025
Australian Retirement TrustAccumulationDiversified Balanced (Accumulation)
0.00%
$13,17331 December 2025
Australian Retirement TrustRetirementDiversified Balanced Risk-Adjusted (Income)
0.00%
$9,78531 December 2025
Australian Retirement TrustAccumulationDiversified Balanced Risk-Adjusted (Accumulation)
0.00%
$6,40331 December 2025
Australian Retirement TrustRetirementDiversified Balanced (Income)
0.00%
$4,05131 December 2025
Australian Retirement TrustRetirementDiversified Conservative-Balanced (Income)
0.00%
$3,09831 December 2025
Australian Retirement TrustAccumulationDiversified Conservative-Balanced (Accumulation)
0.00%
$2,66231 December 2025
Australian Retirement TrustRetirementDiversified High Growth (Income)
0.00%
$1,48931 December 2025
Australian Retirement TrustRetirementDiversified Conservative (Income)
0.00%
$1,22331 December 2025
Australian Retirement TrustAccumulationDiversified Conservative (Accumulation)
0.00%
$1,21731 December 2025

This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.

Methodology — how holdings are sourced, resolved and aggregated.

LookThrough shows the actual holdings inside Australian super funds, with cross-fund look-through.

  • 4 of 86 funds
  • 36 of 111 options reviewed
  • 7,010 of 7,168 securities reviewed

© 2026 LookThrough. Factual disclosure information — not financial advice, a rating or a recommendation.